Yeo-Kyeoung Kim

Jong-Ho Won, Sang Kyun Sohn, Sung-Hoon Jung, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category

J. Huh, Hyeoung-Joon Kim, S. Sohn, 2013, Genes, chromosomes & cancer.

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Chonnam medical journal.

Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy

H. Lee, Je-Jung Lee, I. Chung, 2011, Cellular and Molecular Immunology.

Polymorphisms in DNA Repair Genes and MDR1 and the Risk for Non-Hodgkin Lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2014, International journal of molecular sciences.

Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status

M. Shin, Jin-Su Choi, H. Kim, 2012, Leukemia and Lymphoma.

Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.

Jinny Park, C. Jung, Y. Mun, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates

J. Rhee, Je-Jung Lee, I. Chung, 2007, Leukemia & lymphoma.

Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia

Hee-Jin Kim, Sun-Hee Kim, J. Huh, 2011, Annals of Hematology.

A genome‐wide single‐nucleotide polymorphism‐array can improve the prognostic stratification of the core binding factor acute myeloid leukemia

Sun-Hee Kim, Jinny Park, Y. Mun, 2012, American journal of hematology.

Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, Blood research.

STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, M. Shin, 2017, Blood research.

Clinical significance of clonality and Epstein‐Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis

Je-Jung Lee, Hyeoung-Joon Kim, S. Kim, 2010, American journal of hematology.

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.

Marc S. Tyndel, Zhaolei Zhang, J. Lipton, 2017, Blood.

Efficacy of administration of weekly docetaxel combined with platinum as a first-line treatment for patients with advanced non-small cell lung cancer

K. Lee, W. Lee, D. Hyun, 2007 .

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea

Jinny Park, J. Cheong, C. Jung, 2018, Cancer medicine.

Korean Guidelines for Treating Chronic Myelogenous Leukemia - The Korean Society of Hematology Chronic Myelogenous Leukemia Working Party

J. Cheong, C. Jung, Joon Seong Park, 2015 .

Guidelines for the management of myeloproliferative neoplasms

Jinny Park, C. Jung, S. Bang, 2015, The Korean journal of internal medicine.

Guidelines for the management of myeloprolifer- ative neoplasms

Jinny Park, C. Jung, C. Choi, 2015 .

Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2008, Journal of Korean medical science.

Steroid-refractory Autoimmune Hemolytic Anemia Following Unrelated Allogeneic Peripheral Blood Stem Cell Transplantation

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008 .

The Feasibility and Clinical Efficacy of In Vivo Adsorption of Isohemagglutinins with Fresh Frozen Plasma (FFP) Infusion in Major ABOincompatible Allogeneic Stem Cell Transplantation

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2005 .

Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes

J. Cheong, Y. Min, J. Eom, 2014, PloS one.

Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry

Sung-Soo Yoon, Jin Seok Kim, S. Sohn, 2013, International Journal of Hematology.

Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV‐seropositive recipients and donors

Je-Jung Lee, Y. Cho, Hyeoung-Joon Kim, 2008, American journal of hematology.

Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry

Sung-Soo Yoon, Jin Seok Kim, S. Sohn, 2016, Journal of Korean medical science.

Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry

Sung-Soo Yoon, Jin Seok Kim, S. Sohn, 2015, Annals of Hematology.

Renal Adverse Effect of Anagrelide in Patients with Myeloproliferative Neoplasms

Je-Jung Lee, Hyeoung-Joon Kim, N. Kim, 2011 .

Polymorphisms of drug‐metabolizing genes and risk of non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2009, American journal of hematology.

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

Sukjoong Oh, Y. Do, Y. Mun, 2016, Leukemia & lymphoma.

Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

Sukjoong Oh, M. Mauro, Y. Do, 2013, American journal of hematology.

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients

J. Cheong, Y. Min, C. Jung, 2012, Medical Oncology.

Association with TP53 codon 72 polymorphism and the risk of non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2010, American journal of hematology.

Ileovesical Fistula Caused by Hepatocellular Carcinoma

S. Choi, I. Chung, Deok-Hwan Yang, 2005, The Korean journal of internal medicine.

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.

H. Won, J. Lipton, Jong-Won Kim, 2011, Blood.

Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study.

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Clinical lymphoma, myeloma & leukemia.

Serum Lactate Dehydrogenase with a Systemic Inflammation Score Is Useful for Predicting Response and Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Acta Haematologica.

The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma

J. Min, Y. Jeong, Je-Jung Lee, 2009, Annals of Hematology.

Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.

M. Shin, Jin-Su Choi, H. Kim, 2009, Leukemia research.

DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2011, Journal of Korean medical science.

Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Journal of Korean medical science.

Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma

Jin-Su Choi, H. Kim, Je-Jung Lee, 2007, American journal of hematology.

Association between folate‐metabolizing pathway polymorphism and non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2008, British journal of haematology.

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

H. Lee, B. Park, Je-Jung Lee, 2011, Cellular and Molecular Immunology.

Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy

H. Yhim, Je-Jung Lee, Hyeoung-Joon Kim, 2013, American journal of hematology.

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Annals of Hematology.

Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation

Je-Jung Lee, I. Chung, Y. Mun, 2007, American journal of hematology.

Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2015, Chonnam medical journal.

Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Leukemia research.

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome

J. Cheong, Y. Min, C. Jung, 2015, Acta Haematologica.

Clinical Efficacy of Thalidomide Containing Regimens as a Primary Therapy in Patients with Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2006 .

The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma.

J. Rhee, S. Chung, J. Park, 2009, Leukemia research.

Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins

H. Lee, Je-Jung Lee, I. Chung, 2011, Annals of Hematology.

Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells

Je-Jung Lee, I. Chung, P. Kalinski, 2010, Annals of Hematology.

Induction of Myeloma Cell Line-specific Cytotoxic T Lymphocytes using Monocyte-derived Dendritic Cells Pulsed with Myeloma Cell Line Lysates

J. Park, Je-Jung Lee, I. Chung, 2006 .

Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation

Jinny Park, J. Cheong, Byeong-Bae Park, 2015, Blood research.

Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Annals of Hematology.

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

J. Cheong, Kihyun Kim, Jin Seok Kim, 2016, BMC Cancer.

Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A

Je-Jung Lee, Hyeoung-Joon Kim, Kyeong-Soo Park, 2013, Journal of Korean medical science.

Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience

Doyeun Oh, C. Jung, H. Yhim, 2011, International journal of hematology.

ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population

H. Yhim, Y. Kim, H. Kim, 2012, Thrombosis and Haemostasis.

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

I. Oh, K. Na, G. Song, 2016, Journal of Korean medical science.

Genome‐wide genotype‐based risk model for survival in acute myeloid leukaemia patients with normal karyotype

Zhaolei Zhang, Jinny Park, E. Shin, 2013, British journal of haematology.

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Sukjoong Oh, Y. Do, Y. Mun, 2013 .

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma

J. Min, Y. Do, S. Kweon, 2015, BMC Cancer.

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

J. H. Lee, Kihyun Kim, Sukjoong Oh, 2010, Annals of Hematology.

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

H. Yhim, Y. Mun, M. Shin, 2013 .

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Korean Guidelines for the Prevention of Venous Thromboembolism

Sung-Soo Yoon, S. Bang, Inho Kim, 2010, Journal of Korean medical science.

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016, Journal of Korean medical science.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2016, Annals of Hematology.

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

J. Cheong, Kihyun Kim, Jin Seok Kim, 2016, BMC Cancer.

The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2007, Cancer research and treatment : official journal of Korean Cancer Association.

Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2013, International Journal of Hematology.

The Prognostic Significance Of Interim PET/CT Using Visual, SUV-Based and MTV-Based Assessment In Treatment Of Peripheral T Cell Lymphoma

Sang-Woo Lee, J. Min, Y. Do, 2013 .

Induction of leukemic‐cell‐specific cytotoxic T lymphocytes by autologous monocyte‐derived dendritic cells presenting leukemic cell antigens

J. Rhee, Je-Jung Lee, I. Chung, 2006, Journal of clinical apheresis.

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort

H. Eom, M. K. Kim, Jae Hoon Lee, 2017, Blood research.

The clonal origins of leukemic progression of myelodysplasia

S. Y. Kim, Marc S. Tyndel, Zhaolei Zhang, 2016, Leukemia.

A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment

J. Min, Y. Jeong, Je-Jung Lee, 2011, Case Reports in Oncology.

All-trans Retinoic Acid-induced Nephrotic-range Proteinuria in a Patient with Acute Promyelocytic Leukemia

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2008 .

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Zhaolei Zhang, C. Jung, Y. Lee, 2017, Oncotarget.

Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression

H. Choi, E. Hwang, Je-Jung Lee, 2016, Annals of Hematology.

The Clinical Efficacy of R-CHOP Chemotherapy in Patients with Previously Untreated Diffuse Large B-cell Lymphoma

H. Song, Y. Do, Je-Jung Lee, 2004 .

Prognostic Significances of ABCG-2 and hOCT-1 Gene Expression in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate.

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2009 .

Vertical transumbilical incision versus left lower transverse incision for specimen retrieval during laparoscopic colorectal surgery

J. Huh, Y. J. Kim, Yeo-Kyeoung Kim, 2013, Techniques in Coloproctology.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Leukemia research.

Metabolic Syndrome Is Associated With Venous Thromboembolism in the Korean Population

W. Ageno, Taeseung Lee, W. Choi, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Clinicopathological characteristics of T1 colorectal cancer without background adenoma

J. Oh, H. Chang, D. Sohn, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients.

H. W. Lee, Y. Kim, H. Ryoo, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome

Jinny Park, Y. Min, C. Choi, 2011, Haematologica.